These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16675374)

  • 21. Oxcarbazepine monotherapy in postherpetic neuralgia unresponsive to carbamazepine and gabapentin.
    Criscuolo S; Auletta C; Lippi S; Brogi F; Brogi A
    Acta Neurol Scand; 2005 Apr; 111(4):229-32. PubMed ID: 15740573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical aspects of oxcarbazepine treatment.
    Dam M
    Epilepsia; 1994; 35 Suppl 3():S23-5. PubMed ID: 8156977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective serotonin reuptake inhibitors and the risk of restless legs syndrome: a symmetry analysis.
    Dunvald AD; Henriksen DP; Hallas J; Christensen MMH; Lund LC
    Eur J Clin Pharmacol; 2020 May; 76(5):719-722. PubMed ID: 32062781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serotonin syndrome associated to the use of paroxetine. Case report].
    Cavallazzi LO; Grezesiuk AK
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):886-9. PubMed ID: 10751931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.
    Dardis C; Omoregie E; Ly V
    Neurologist; 2012 Jul; 18(4):204-5. PubMed ID: 22735246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restless legs syndrome induced by escitalopram: case report and review of the literature.
    Page RL; Ruscin JM; Bainbridge JL; Brieke AA
    Pharmacotherapy; 2008 Feb; 28(2):271-80. PubMed ID: 18225972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of betahistine mesilate tablets as augmentation for oxcarbazepine and carbamazepine in treating vestibular paroxysmia.
    Xue H; Xiang W; Yu Y; Liu G; Chong Y; Zhou J
    Drug Des Devel Ther; 2018; 12():837-843. PubMed ID: 29695895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Restless Legs Syndrome Due to the Use of Trazodone: A Case Report.
    Yilbaş B
    Turk Psikiyatri Derg; 2022; 33(1):70-72. PubMed ID: 35343583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxcarbazepine therapy in paroxysmal kinesigenic choreoathetosis.
    Gökçay A; Gökçay F
    Acta Neurol Scand; 2000 May; 101(5):344-5. PubMed ID: 10987326
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxcarbazepine therapy in very young children: a single-center clinical experience.
    Kothare SV; Mostofi N; Khurana DS; Mohsem B; Melvin JJ; Hardison HH; Valencia I; Legido A
    Pediatr Neurol; 2006 Sep; 35(3):173-6. PubMed ID: 16939855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors].
    Apelland T; Gedde-Dahl T; Dietrichson T
    Tidsskr Nor Laegeforen; 1999 Feb; 119(5):647-50. PubMed ID: 10095385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carbamazepine overdose following administration of sertraline: relation to serotonergic syndrome?].
    Vercueil L; Adriantseheno LM; Hirsch E
    Therapie; 1998; 53(5):502-4. PubMed ID: 9921045
    [No Abstract]   [Full Text] [Related]  

  • 34. Oxcarbazepine for epilepsy--a useful new choice?
    Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxcarbazepine-induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).
    D'Orazio JL
    Clin Toxicol (Phila); 2008 Dec; 46(10):1093-4. PubMed ID: 18821094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticonvulsants to treat idiopathic restless legs syndrome: systematic review.
    Conti CF; Oliveira MM; Valbuza JS; Prado LB; Carvalho LB; Prado GF
    Arq Neuropsiquiatr; 2008 Jun; 66(2B):431-5. PubMed ID: 18641891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxcarbazepine and spasticity: further observations.
    Bittencourt PR
    Arq Neuropsiquiatr; 1988 Dec; 46(4):382-4. PubMed ID: 3072937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oxcarbazepine-induced syndrome of inappropriate secretion of antidiuretic hormone.
    Cilli AS; Algun E
    J Clin Psychiatry; 2002 Aug; 63(8):742. PubMed ID: 12197457
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible serotonin syndrome from paroxetine and clonazepam.
    Rella JG; Hoffman RS
    J Toxicol Clin Toxicol; 1998; 36(3):257-8. PubMed ID: 9656985
    [No Abstract]   [Full Text] [Related]  

  • 40. SIB 1893, a selective mGluR5 receptor antagonist, potentiates the anticonvulsant activity of oxcarbazepine against amygdala-kindled convulsions in rats.
    Borowicz KK; Łuszczki JJ; Czuczwar SJ
    Pol J Pharmacol; 2004; 56(4):459-64. PubMed ID: 15520501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.